Search clinical trials for: DWP14012 Bmg

Total 10994 results

Hellenic Institute for the Study of Sepsis
Radboud University Medical Center

Completed

Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly (ACTIVATE)

Mortality | Infection | Hospitalization

Greece
Bristol-Myers Squibb

Completed

Pharmacokinetic and Metabolism of [14^C] BMS-986177 in Healthy Male Participants

Thrombosis

United States
Novartis Pharmaceuticals
NantCell, Inc.

Terminated

A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors

PIK3CA Mutated Advanced Solid Tumors | PIK3CA Amplified Advanced Solid Tumors

Spain, Belgium, United States, Canada
Bristol-Myers Squibb

Completed

Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Cancer - Solid Tumors and B-Cell Non-Hodgkin's Lymphoma

United States, France, Spain, Germany
Bristol-Myers Squibb

Completed

A Phase I Study of BMS-690514 in Combination With Paclitaxel and Carboplatin

Cancer (Solid Tumors)

United Kingdom, United States, Canada
Bristol-Myers Squibb

Terminated

A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 1)

Advanced Solid Tumors

United States, Netherlands
Bristol-Myers Squibb

Completed

Absorption, Distribution, Metabolism and Excretion (ADME) Study of BMS-986020

Immunosuppression For Disease
Bristol-Myers Squibb

Terminated

Safety and Pharmacology Study of BMS-866949

Major Depression

Sweden
University Hospital, Strasbourg, France

Completed

Bone Mineral Density (BMD) in HIV Infection

Osteoporosis | Osteopenia

France
Bristol-Myers Squibb

Completed

Safety, Pharmacokinetics and Pharmacodynamics Study of BMS-866949 in Healthy Subjects

Depression

Sweden
Bristol-Myers Squibb

Completed

Single Dose Study of BMS-820836

Depression

Canada
Amgen

Completed

A Safety and Efficacy Study to Evaluate AMG 531 Treatment in Subject With Myelodysplastic Syndrome Receiving Revlimid

Myelodysplastic Syndromes | Thrombocytopenia
Bristol-Myers Squibb

Completed

A Phase I Study to Assess the Electrophysiologic Effects of BMS-394136 on the Atrium and Ventricle in Patients With Dual-Chamber Pacemakers or Defibrillators

Heart Diseases

United States
VA Office of Research and Development
Medical University of South Carolina

Completed

Proteolytic Enzyme Induction Within the Human Myocardial Interstitium

Heart Disease

United States
Radboud University Medical Center

Active, not recruiting

BCG-induced Epigenetic Modifications in the NEXT Generation (NEXT)

Epigenetics | Trained Immunity | BCG Vaccine

Netherlands
BioMarin Pharmaceutical

Active, not recruiting

An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With Achondroplasia

Achondroplasia

United States, Australia, Japan, United Kingdom
University of Alberta

Withdrawn

A Study to Systematically Assess the Efficacy and Safety of Intravenous Albumin Infusions in Severe POTS

Postural Orthostatic Tachycardia Syndrome
BioMarin Pharmaceutical

Completed

Long-Term Efficacy and Safety Extension Study of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)

Morquio A Syndrome | MPS IVA | Mucopolysaccharidosis IV A

United States, Canada, France, Taiwan, Argentina, Colombia, Spain, Turkey, Japan, Saudi Arabia, Netherlands, Denmark, Korea, Republic of, Brazil, United Kingdom, Germany, Norway, Portugal, Italy, Qatar
Kael-GemVax Co., Ltd.
National Cancer Institute (NCI)

Unknown

Vaccine Therapy in Treating Patients With Stage D0 Prostate Cancer

Prostate Cancer

United States
Boehringer Ingelheim

Terminated

Dabigatran Etexilate in Patients With Mechanical Heart Valves (RE-ALIGN)

Heart Valve Diseases

Belgium, Canada, Czech Republic, Denmark, France, Germany, Netherlands, Norway, Poland, Sweden
Boehringer Ingelheim

Terminated

Follow on Study From RE-ALIGN

Thromboembolism | Heart Valve Prosthesis

Belgium, Canada, Czech Republic, Denmark, France, Germany, Netherlands, Norway, Poland
NYU Langone Health

Completed

Impact of Estrogen on Fear Extinction R61

Fear | Fear; Examination, Phobic

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Rilotumumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
Bristol-Myers Squibb

Recruiting

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma (RELATIVITY-069)

Lymphoma, Non-Hodgkin | Hodgkin Disease

United States, France, Netherlands, Australia, United Kingdom, Italy, Spain, Germany
Daewoong Pharmaceutical Co. LTD.

Enrolling by invitation

Drug-drug Interactions Between DWC202211 and DWC202212 in Healthy Subjects (DWJ1610)

Drug-drug Interaction

Korea, Republic of
Bristol-Myers Squibb

Terminated

An Investigational Immuno-Therapy Study of Experimental Medication BMS-986242 Given in Combination With Nivolumab in Patients With Advanced Cancer

Cancer

United States
Amgen

Completed

Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC)

Metastatic Colorectal Cancer | Colorectal Cancer | Rectal Cancer | Colon Cancer | Gastrointestinal Cancer
Mylan Pharmaceuticals Inc

Completed

Food Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg

Healthy

United States
Lene Bergendal Solberg
Vestre Viken Hospital Trust; Diakonhjemmet Hospital; Roche Diagnostics

Recruiting

Zoledronate Early to Hip Fracture Patients - Safe and Effective? (ZEBRA)

Hip Fractures | Osteoporosis

Norway
Bandim Health Project
Odense University Hospital; Odense Patient Data Explorative Network; Municipality...

Completed

Using BCG to Protect Senior Citizens During the COVID-19 Pandemic

Covid19 | Immunosenescence | Vaccine Preventable Disease | Morbidity | Non-specific Effects of Vaccines | Heterologous Immunity

Denmark
Beijing VDJBio Co., LTD.

Recruiting

A Study of Anti-IL-6R mAb Injection in Patients With iMCD

Idiopathic Multicentric Castleman's Disease

China
Seoul National University Hospital
Ministry of Trade, Industry & Energy, Republic of Korea

Recruiting

Feasibility and Safety of In-bed Self-exercise in Patients With Subacute Stroke

Stroke

Korea, Republic of
Amgen

Recruiting

A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE) (ROCKET-Ignite)

Atopic Dermatitis

Japan, Korea, Republic of, United States, Taiwan, Spain, Germany, Croatia, China, Greece, Italy, Czechia, Brazil, Poland, Portugal, Slovakia, Argentina, Canada, Puerto Rico, Hungary, Latvia, Netherlands
BioMarin Pharmaceutical

Recruiting

Safety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior Inhibitors (GENEr8-INH)

Hemophilia A With Inhibitor | Hemophilia A With Anti Factor VIII

United States, United Kingdom, Taiwan, Israel, Korea, Republic of, South Africa, Brazil, Italy, Germany
Amgen

Active, not recruiting

A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-SHUTTLE)

Atopic Dermatitis

Belgium, Spain, China, Germany, United States, Austria, France, Hungary, Switzerland, Canada, United Kingdom, Bulgaria, Australia, Netherlands, Malaysia, Singapore, Slovenia, Italy, Japan, Argentina, Greece, Turkey, Poland, Puerto Rico, Romani... and more
University Hospital, Lille
Janssen Pharmaceuticals

Terminated

Changes in Body Composition Under Ustekinumab in PsA (STELARA-CC)

Psoriatic Arthritis

France
Peking University Third Hospital

Completed

Application of Tremor Analysis in Parkinson's Disease and Its Related Diseases

Parkinson Disease

China
Otsuka Pharmaceutical Co., Ltd.

Completed

A Clinical Pharmacology Trial of Brexpiprazole Once-weekly (QW) Formulation Administered as Single and Multiple Oral Doses

Schizophrenia

Japan
Chong Kun Dang Pharmaceutical

Completed

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-374 5 mg in Healthy Volunteers

Rheumatoid Arthritis

Korea, Republic of
BioMarin Pharmaceutical

Completed

A Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Intracerebroventricular BMN 190 in Patients With Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2) Disease

Batten Disease | CLN2 Disease | Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 | Jansky-Bielschowsky Disease

United States, Italy, Germany, United Kingdom
Vanderbilt University Medical Center

Completed

Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial (PreVent)

Endotracheal Intubation | Respiratory Failure | Respiratory Failure With Hypoxia

United States
Jaeb Center for Health Research

Completed

A Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Type 1 Diabetes (REPLACE-BG)

Type 1 Diabetes

United States
University of Colorado, Denver

Completed

The Diagnosis and Incidence of Critical Illness Polyneuromyopathy in Medical and Neurosurgical ICU Patients

Critical Illness

United States
Hospital General de Niños Pedro de Elizalde

Terminated

Two Bag System for Hydration in Diabetes

Diabetes | Ketoacidosis

Argentina
R-Pharm

Completed

Clinical Study of Ixabepilone (BMS-247550) by Every-3-week Dosing Regimen in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and Who Are Taxane Resistant

Metastatic Breast Cancer
University of Missouri-Columbia

Withdrawn

Food Allergy - Tubes - Adenoids (FATA) Trial (FATA)

Food Hypersensitivity | Otitis Media With Effusion

United States
Ono Pharmaceutical Co. Ltd

Completed

A Study to Investigate the Effect of ONO-8539 on Acid-Induced Oesophageal Hypersensitivity in Healthy Volunteers

Acid Reflux

United Kingdom
The Catholic University of Korea

Completed

Electrodiagnostic Parameters in Patients With Impaired Glucose Tolerance and Diabetes Mellitus

Impaired Glucose Tolerance | DM | Peripheral Polyneuropathy

Korea, Republic of
Bristol-Myers Squibb

Completed

A Study of Nivolumab in Combination With Ipilimumab in Chinese Participants With Previously Treated Advanced or Recurrent Solid Tumors

Solid Tumor

China
Bristol-Myers Squibb
Nektar Therapeutics

Completed

A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma

Melanoma

Canada, Australia, France, Italy, Brazil, United States, Argentina, Austria, Belgium, Chile, Czechia, Finland, Germany, Greece, Ireland, Israel, Mexico, Netherlands, New Zealand, Poland, Portugal, Romania, Russian Federation, Spain, Sweden and more

Search clinical trials for: DWP14012 Bmg

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations